46
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

The Self-Assembly of Diblock Copolymers MePEG-b-PAAm into Micellar Structures and Their Interaction with Doxorubicin

, , , &
Pages 166/[398]-172/[404] | Published online: 03 Mar 2011
 

Abstract

The micellization of asymmetric diblock copolymers (DBC) MePEG-b-PAAm formed by monomethoxy-poly(ethylene)oxide (MePEG) and polyacrylamide (PAAm) has been studied in water, a water/alcohol mixture, and a NaCl solution. The effect of added NaCl on the critical micellization concentration of DBC water solutions was examined. The interaction between DBC and antitumor drug doxorubicin is discussed. The analysis of the UV spectrum of doxorubicin is performed.

Notes

1Weight fraction of MePEG block.

2Ratio of PAA blocks and PEO blocks.

a Critical micellization concentration.

b Gibbs free micellization energy.

1λ abs – transition wavelength, f – transition oscillator strength.

2Configuration of the transition Ψk is expressed by the relation , k – transition number, i – number of filled MO, j – number of vacant MO. In the table, the configurations with d2 > 0.1 are shown.

3Localization of three fragments X, Y, Z is shown in Figure . Localization of the transition is A if (LX + LZ) >> (LY +LZ); localization of the transition is B if (LX + LZ) << (LY + LZ); and the transition is general molecular if LX ≈ LY.

4Localization of the fragments A and B is shown in Figure .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.